Intrinsic capacity and the trajectory of ischemic heart disease and its complications: the mediating role of insulin resistance indices
Maturitas · 2026-08 · 211 · 109049
DOI: 10.1016/j.maturitas.2026.109049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Maturitas, 2026-08. Verfasst von Nana Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, 450001, Henan, China. Hauptthemen laut MEDLINE: Myocardial Ischemia, Insulin Resistance. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
OBJECTIVE This study investigated the associations of intrinsic capacity, a multidomain measure of functional health, with the incidence and progression of ischemic heart disease, and the mediation of such associations by indices related to insulin resistance (IR). METHODS We included 386,462 adults from the UK Biobank who were free of ischemic heart disease and its associated complications, including heart failure and arrhythmia, at baseline. Associations were estimated using Cox models, and multistate models for transitions. Mediation by IR-related indices was quantified in a counterfactual framework. RESULTS Over a median 13.68 years of follow-up, 29,994 ischemic heart disease events occurred. Hazard ratios (95% confidence intervals) for ischemic heart disease were 1.15 (1.11-1.18), 1.38 (1.33-1.43), 1.68 (1.61-1.75), and 2.24 (2.12-2.37) for intrinsic capacity scores of 1, 2, 3, and ≥4 versus 0. Estimates from the multistate model for the transition from baseline to ischemic heart disease were consistent with the Cox results. Hazard ratios (95% confidence intervals) for transition from ischemic heart disease to death were 1.32 (1.14-1.53) for intrinsic capacity score 3 and 1.46 (1.21-1.74) for intrinsic capacity score ≥ 4, and 1.30 (1.09-1.56) from complications to death for intrinsic capacity score ≥ 4. IR-related indices accounted for 6.77-22.40% of the association between intrinsic capacity and ischemic heart disease, 5.38-24.24% for complications, and 2.22-10.04% for death. CONCLUSIONS Lower intrinsic capacity was associated with higher risks of ischemic heart disease and its progression, partly through IR-related pathways, supporting metabolic dysfunction as a modifiable target for early risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, 450001, Henan, China.
- Department of Cardiology, the First College of Clinical Medical Science, China Three Gorges University and Yichang Central People's Hospital, Yichang, 443003, Hubei, China. Electronic address: fanzhixing@ctgu.edu.cn.
- Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, 450001, Henan, China. Electronic address: xzshi@zzu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, N., Yang, Y., Jia, X., Yang, C., Wang, Y., Fan, J., Zhao, C., Niu, Y., Fan, Z., & Shi, X. (2026). Intrinsic capacity and the trajectory of ischemic heart disease and its complications: the mediating role of insulin resistance indices. Maturitas, 211, 109049. https://doi.org/10.1016/j.maturitas.2026.109049
Vancouver
Wang N, Yang Y, Jia X, Yang C, Wang Y, Fan J, et al. Intrinsic capacity and the trajectory of ischemic heart disease and its complications: the mediating role of insulin resistance indices. Maturitas. 2026;211:109049. doi:10.1016/j.maturitas.2026.109049
BibTeX
@article{Wang2026,
author = {Wang, Nana and Yang, Yongli and Jia, Xiaocan and Yang, Chaojun and Wang, Yuping and Fan, Jingwen and Zhao, Chenyu and Niu, Yali and Fan, Zhixing and Shi, Xuezhong},
title = {Intrinsic capacity and the trajectory of ischemic heart disease and its complications: the mediating role of insulin resistance indices},
journal = {Maturitas},
year = {2026},
volume = {211},
pages = {109049},
doi = {10.1016/j.maturitas.2026.109049}
}
EUVIMED